NDMI, total white cell count, and their interaction were significantly associated with CD4 T-cell levels in whole blood and explained substantial variation in CD4 counts among glioma subjects (r2 = 0.64; p < 0.001) (Table 2). This evidence concerns the gene CD4 and central nervous system cancer.